Thrombin activatable fibrinolysis inhibitor (TAFI) polymorphisms and plasma TAFI levels measured with an ELISA insensitive to isoforms in patients with venous thromboembolic disease (VTD).

Suppr

超能文献

作者信息

Verdú José, Marco Pascual, Benlloch Susana, Sanchez José, Lucas Javier

出版信息

Thromb Haemost. 2006 Mar;95(3):585-6. doi: 10.1160/TH05-09-0620.

DOI:10.1160/TH05-09-0620

PMID:16525595

Abstract

摘要

相似文献

Thrombin activatable fibrinolysis inhibitor (TAFI) polymorphisms and plasma TAFI levels measured with an ELISA insensitive to isoforms in patients with venous thromboembolic disease (VTD).

Thromb Haemost. 2006 Mar;95(3):585-6. doi: 10.1160/TH05-09-0620.

Quantification of thrombin activatable fibrinolysis inhibitor (TAFI) gene polymorphism effects on plasma levels of TAFI measured with assays insensitive to isoform-dependent artefact.

Thromb Haemost. 2005 Aug;94(2):373-9. doi: 10.1160/TH04-08-0497.

Impact of genetic polymorphisms in thrombin activatable fibrinolysis inhibitor (TAFI) on venous thrombosis disease: A meta-analysis.

Gene. 2015 Sep 15;569(2):173-81. doi: 10.1016/j.gene.2015.06.014. Epub 2015 Jun 10.

Association between thrombin activatable fibrinolysis inhibitor genotype and levels in plasma: comparison of different assays.

Br J Haematol. 2004 Mar;124(5):659-65. doi: 10.1111/j.1365-2141.2004.04824.x.

Thrombin-activatable fibrinolysis inhibitor and the risk for recurrent venous thromboembolism.

Blood. 2004 May 15;103(10):3773-6. doi: 10.1182/blood-2003-10-3422. Epub 2004 Jan 22.

Plasma levels of unactivated thrombin activatable fibrinolysis inhibitor (TAFI) are down-regulated in young adult women: analysis of a normal Japanese population.

Microbiol Immunol. 2007;51(5):507-17. doi: 10.1111/j.1348-0421.2007.tb03939.x.

Plasma thrombin-activatable fibrinolysis inhibitor antigen concentration and genotype in relation to myocardial infarction in the north and south of Europe.

Arterioscler Thromb Vasc Biol. 2002 May 1;22(5):867-73. doi: 10.1161/01.atv.0000015445.22243.f4.

Association between thrombin-activatable fibrinolysis inhibitor (TAFI) and clinical outcome in patients with unstable angina pectoris.

Thromb Haemost. 2003 Jul;90(1):92-100.

Thrombin-activatable fibrinolysis inhibitor (TAFI) levels and its polymorphism rs3742264 are associated with dyslipidemia in a cohort of Brazilian subjects.

Clin Chim Acta. 2014 Jun 10;433:76-83. doi: 10.1016/j.cca.2014.02.030. Epub 2014 Mar 11.

Thr325Ile polymorphism of the TAFI gene is related to TAFI antigen plasma levels and angiographic restenosis after percutaneous coronary interventions.

Thromb Res. 2004;114(2):137-41. doi: 10.1016/j.thromres.2004.06.003.

引用本文的文献

Carboxypeptidase U (CPU, TAFIa, CPB2) in Thromboembolic Disease: What Do We Know Three Decades after Its Discovery?

Int J Mol Sci. 2021 Jan 17;22(2):883. doi: 10.3390/ijms22020883.

Sex-specific effect of CPB2 Ala147Thr but not Thr325Ile variants on the risk of venous thrombosis: A comprehensive meta-analysis.

PLoS One. 2017 May 26;12(5):e0177768. doi: 10.1371/journal.pone.0177768. eCollection 2017.

Association between polymorphisms in the flanking region of the TAFI gene and atherosclerotic cerebral infarction in a Chinese population.

Lipids Health Dis. 2014 May 13;13:80. doi: 10.1186/1476-511X-13-80.

Does decreased fibrinolysis have a role to play in the development of non-neoplastic portal vein thrombosis in patients with hepatic cirrhosis?

Intern Emerg Med. 2014 Jun;9(4):397-403. doi: 10.1007/s11739-013-0929-7. Epub 2013 Mar 17.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验